Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 09-2009 | 07-2009 | 06-2009 | 04-2009 | |
| Sales | 265,600 | 177,400 | 283,400 | 290,300 | 275,100 |
| Cost of Goods | 173,500 | 117,700 | 184,700 | 188,100 | 185,000 |
| Gross Profit | 92,100 | 84,100 | 98,700 | 102,200 | 90,100 |
| Operating Expenses | 96,700 | 71,500 | 86,300 | 80,400 | 92,500 |
| Operating Income | -4,100 | -100 | 13,100 | 21,900 | -2,400 |
| Other Income | 9,100 | 51,300 | -7,100 | -5,800 | -5,800 |
| Pre-tax Income | 5,000 | 51,200 | 6,000 | 16,100 | -8,200 |
| Income Tax | 1,400 | 3,600 | 400 | 900 | 1,400 |
| Net Income Continuous | 3,600 | -14,900 | 5,600 | 15,200 | -9,600 |
| Net Income Discontinuous | -14,600 | -14,700 | -6,400 | -8,300 | -1,300 |
| Minority Interests | 200 | -100 | N/A | 100 | N/A |
| Net Income | $-11,200 | $29,400 | $-800 | $6,800 | $-10,900 |
| EPS Basic Total Ops | -0.12 | 0.16 | -0.01 | 0.07 | -0.11 |
| EPS Basic Continuous Ops | 0.04 | -0.11 | 0.06 | 0.16 | -0.10 |
| EPS Basic Discontinuous Ops | -0.16 | -0.21 | -0.07 | -0.09 | -0.01 |
| EPS Diluted Total Ops | -0.11 | -0.30 | -0.01 | 0.07 | -0.11 |
| EPS Diluted Continuous Ops | 0.04 | -0.11 | 0.06 | 0.16 | -0.10 |
| EPS Diluted Discontinuous Ops | -0.15 | -0.21 | -0.07 | -0.09 | -0.01 |
| EBITDA(a) | $11,500 | $411,700 | $437,400 | $-312,900 | $-337,200 |